Ekso bionics announces continued adoption of evo™ with flexible subscription-based order from cloverdale foods company

Richmond, calif., nov. 10, 2020 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (the “company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the continued adoption of its latest industry exoskeleton innovation, evo, with a subscription-based order by cloverdale foods company, a fourth generation, family-owned meat company.
EKSO Ratings Summary
EKSO Quant Ranking